Identification of Novel Circulating miRNA Biomarkers for the Diagnosis of Esophageal Squamous Cell Carcinoma and Squamous Dysplasia

被引:37
作者
Shen, Yi [1 ]
Ding, Yuanjie [1 ]
Ma, Qing [2 ,3 ]
Zhao, Lei [4 ]
Guo, Xudong [1 ]
Shao, Yi [1 ]
Niu, Chen [1 ]
He, Yan [1 ]
Zhang, Feng [1 ]
Zheng, Deqiang [1 ]
Wei, Wenqiang [2 ,3 ]
Liu, Fen [1 ]
机构
[1] Capital Med Univ, Beijing Municipal Key Lab Clin Epidemiol, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China
[2] Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, Beijing 100021, Peoples R China
[3] Peking Union Med Coll, Beijing 100021, Peoples R China
[4] Univ Iowa, Carver Coll Med, Holden Comprehens Canc Ctr, Dept Mol Physiol & Biophys, Iowa City, IA USA
基金
中国国家自然科学基金; 北京市自然科学基金;
关键词
MICRORNA EXPRESSION PROFILE; HEPATOCELLULAR-CARCINOMA; DIFFERENTIAL EXPRESSION; CANCER; SERUM; SIGNATURES; PANEL; PROGRESSION; PROGNOSIS; MIR-92A;
D O I
10.1158/1055-9965.EPI-18-1199
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Circulating miRNAs have been identified as diagnostic biomarkers for esophageal squamous cell carcinoma (ESCC), but their efficacy in discovering early-stage ESCC is still unsatisfying. Esophageal squamous dysplasia (ESD) is the precursor lesion of ESCC. Notably, little is known about the role(s) of circulating miRNAs in identifying ESD. In this study, we, therefore, aimed to identify serum miRNAs as novel diagnostic markers for detecting ESD and ESCC. Methods: The genome-wide miRNA expression was profiled in 104 (52 ESCC and 52 controls) serum samples using microarray. Seven candidate miRNAs from the microarray assay were evaluated for their diagnostic performance in another cohort of 266 participants (96 ESCC, 92 ESD, and 78 healthy controls). Results: The serum levels of miR-16-5p, miR-197-5p, miR-451a, and miR-92a-3p were associated with ESCC; the biomarker based on the panel of these four miRNAs could efficiently distinguish patients with ESCC from the controls [AUC = 0.856; 95% confidence interval (CI), 0.794-0.905; P < 0.001]. The serum levels of miR-16-5p, miR-320c, miR-638, and miR-92a-3p were significantly higher in patients with ESD than in controls, and this four-miRNA signature could efficiently differentiate patients with ESD from the controls (AUC = 0.842; 95% CI, 0.778-0.893; P < 0.001). In addition, compared with serum carcinoembryonic antigen and carbohydrate antigen 199, miRNA-based panels had a better diagnostic performance in distinguishing patients with ESCC and ESD from healthy controls. Conclusions: Our study identified two novel panels of circulating miRNAs with high efficiency in detecting ESCC and ESD, suggesting that circulating miRNAs, in particular the combination of them, might serve as noninvasive biomarkers for the early detection of ESCC. Impact: This study suggests the feasibility of using circular miRNA-based blood tests to aid in the detection of ESD and ESCC.
引用
收藏
页码:1212 / 1220
页数:9
相关论文
共 50 条
  • [31] Identification of miRNAs as prognostic factors for esophageal squamous cell carcinoma
    Chen, Meng
    Jin, Dacheng
    Wang, Bing
    Gou, Yunjiu
    Dong, Xinchun
    MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2020, 17 (03) : 2302 - 2309
  • [32] MiRNA expression profile reveals a prognostic signature for esophageal squamous cell carcinoma
    Chen, Zhaoli
    Li, Jiagen
    Tian, Liqing
    Zhou, Chengcheng
    Gao, Yibo
    Zhou, Fang
    Shi, Susheng
    Feng, Xiaoli
    Sun, Nan
    Yao, Ran
    Shao, Kang
    Li, Ning
    Qiu, Bin
    Tan, Fengwei
    He, Jie
    CANCER LETTERS, 2014, 350 (1-2) : 34 - 42
  • [33] Drug repositioning for esophageal squamous cell carcinoma
    Bennett, Adam N.
    Huang, Rui Xuan
    He, Qian
    Lee, Nikki P.
    Sung, Wing-Kin
    Chan, Kei Hang Katie
    FRONTIERS IN GENETICS, 2022, 13
  • [34] Plasma miRNA-506 as a Prognostic Biomarker for Esophageal Squamous Cell Carcinoma
    Li, Shu-Ping
    Su, Hong-Xin
    Zhao, Da
    Guan, Quan-Lin
    MEDICAL SCIENCE MONITOR, 2016, 22 : 2195 - 2201
  • [35] Expression and role of oncogenic miRNA-224 in esophageal squamous cell carcinoma
    He, Xiaoyan
    Zhang, Zhimei
    Li, Ming
    Li, Shuo
    Ren, Lihua
    Zhu, Hong
    Xiao, Bin
    Shi, Ruihua
    BMC CANCER, 2015, 15
  • [36] Evaluation of the circulating level of fibroblast activation protein a for diagnosis of esophageal squamous cell carcinoma
    Liao, Yuehua
    Xing, Shan
    Xu, Banglao
    Liu, Wanli
    Zhang, Ge
    ONCOTARGET, 2017, 8 (18) : 30050 - 30062
  • [37] Identification of genomic biomarkers associated with the clinicopathological parameters and prognosis of esophageal squamous cell carcinoma
    Shi, Zhi-Zhou
    Shang, Li
    Jiang, Yan-Yi
    Shi, Feng
    Xu, Xin
    Wang, Ming-Rong
    Hao, Jia-Jie
    CANCER BIOMARKERS, 2015, 15 (06) : 755 - 761
  • [38] Diagnostic and Prognostic Value of Circulating MicroRNAs for Esophageal Squamous Cell Carcinoma: a Systematic Review and Meta-analysis
    Yao, Can
    Liu, Hai-Ning
    Wu, Hao
    Chen, Yan-Jie
    Li, Yu
    Fang, Ying
    Shen, Xi-Zhong
    Liu, Tao-Tao
    JOURNAL OF CANCER, 2018, 9 (16): : 2876 - 2884
  • [39] Variations of gastric corpus microbiota are associated with early esophageal squamous cell carcinoma and squamous dysplasia
    Nasrollahzadeh, Dariush
    Malekzadeh, Reza
    Ploner, Alexander
    Shakeri, Ramin
    Sotoudeh, Masoud
    Fahimi, Saman
    Nasseri-Moghaddam, Siavosh
    Kamangar, Farin
    Abnet, Christian C.
    Winckler, Bjoern
    Islami, Farhad
    Boffetta, Paolo
    Brennan, Paul
    Dawsey, Sanford M.
    Ye, Weimin
    SCIENTIFIC REPORTS, 2015, 5
  • [40] Identification of Makorin 1 as a novel SEREX antigen of esophageal squamous cell carcinoma
    Shimada, Hideaki
    Shiratori, Tooru
    Yasuraoka, Mari
    Kagaya, Akiko
    Kuboshima, Mari
    Nomura, Fumio
    Takiguchi, Masaki
    Ochiai, Takenori
    Matsubara, Hisahiro
    Hiwasa, Takaki
    BMC CANCER, 2009, 9